Details for Australian Trade Mark No. 1035232 (hide)

Owner Expression Diagnostics, Inc. a Delaware corporation

Convention US 21 JUNE 2004 78/438424

Service Spruson & Ferguson

Various Convention priority claimed: 21 June 2004, United States of America, No. 78/438424 in respect of BIOLOGICAL CHEMICAL DIAGNOSTIC TEST KITS FOR CLINICAL OR MEDICAL LABORATORY USE, NAMELY, FOR USE IN ANALYSIS OF GENE EXPRESSION, GENETICS, SINGLE NUCLEOTIDE P

Filing Date 20 December 2004

Classes

Class 5 Diagnostic preparations for medical purposes; biological chemical diagnostic test kits for clinical or medical laboratory use, including such goods for use in analysis of gene expression, genetics, single nucleotide polymorphism, haplotypes, proteins, and biological samples, for use in detecting diseases, for use in determining the progression of diseases, and for use in determining drug responses; diagnostic medical reagents, chemicals and solid matrix materials for biological, clinical or medical laboratory use for use in diagnosing inflammatory, infectious, central nervous system, cardiovascular, neurological, endocrine, autoimmune and genetic diseases, developmental disorders and cancer

Class 42 Biological research; diagnostic services, including gene expression testing to determine immune response

Event Publications

13 January 2005 Application filed

13 January 2005 Application Accepted

12 May 2005 Trade Mark Registered/Protected

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

1035233-PROSAND

1035231